Staab Thomas R Ii - Net Worth and Insider Trading
Staab Thomas R Ii Net Worth
The estimated net worth of Staab Thomas R Ii is at least $2 Million dollars as of 2024-11-13. Staab Thomas R Ii is the Senior Vice President and CFO of BioCryst Pharmaceuticals Inc and owns about 125,176 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $978,876. Staab Thomas R Ii is also the CFO of LENSAR Inc and owns about 135,131 shares of LENSAR Inc (LNSR) stock worth over $956,727. Details can be seen in Staab Thomas R Ii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Staab Thomas R Ii has not made any transactions after 2022-12-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Staab Thomas R Ii
Staab Thomas R Ii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Staab Thomas R Ii owns 2 companies in total, including LENSAR Inc (LNSR) , and BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Staab Thomas R Ii’s form 4 insider trades.
Insider Ownership Summary of Staab Thomas R Ii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LNSR | LENSAR Inc | 2022-12-07 | Chief Financial Officer |
| BCRX | BioCryst Pharmaceuticals Inc | 2019-05-17 | Senior Vice President and CFO |
Staab Thomas R Ii Latest Holdings Summary
Staab Thomas R Ii currently owns a total of 2 stocks. Among these stocks, Staab Thomas R Ii owns 125,176 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 17, 2019, with a value of $978,876 and a weighting of 50.57%. Staab Thomas R Ii also owns 135,131 shares of LENSAR Inc (LNSR) as of December 7, 2022, with a value of $956,727 and a weighting of 49.43%.
Latest Holdings of Staab Thomas R Ii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2019-05-17 | 125,176 | 7.82 | 978,876 |
| LNSR | LENSAR Inc | 2022-12-07 | 135,131 | 7.08 | 956,727 |
Holding Weightings of Staab Thomas R Ii
Staab Thomas R Ii Form 4 Trading Tracker
According to the SEC Form 4 filings, Staab Thomas R Ii has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 9,750 shares on May 17, 2019, which brought Staab Thomas R Ii around $74,588.
According to the SEC Form 4 filings, Staab Thomas R Ii has made a total of 1 transactions in LENSAR Inc (LNSR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in LENSAR Inc is the acquisition of 2,752 shares on December 7, 2022, which cost Staab Thomas R Ii around $8,696.
Insider Trading History of Staab Thomas R Ii
- 1
Staab Thomas R Ii Trading Performance
GuruFocus tracks the stock performance after each of Staab Thomas R Ii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Staab Thomas R Ii is -1.88%. GuruFocus also compares Staab Thomas R Ii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Staab Thomas R Ii within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Staab Thomas R Ii's insider trading performs compared to the benchmark.
Performance of Staab Thomas R Ii
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.55 | | | | | |
| Relative Return to S&P 500(%) | -16.56 | | | | | |
Staab Thomas R Ii Ownership Network
Ownership Network List of Staab Thomas R Ii
Ownership Network Relation of Staab Thomas R Ii
Staab Thomas R Ii Owned Company Details
What does LENSAR Inc do?
Who are the key executives at LENSAR Inc?
Staab Thomas R Ii is the Chief Financial Officer of LENSAR Inc. Other key executives at LENSAR Inc include 10 percent owner North Run Capital, Lp , 10 percent owner North Run Advisors, Llc , and director & 10 percent owner Thomas B Ellis .
LENSAR Inc (LNSR) Insider Trades Summary
Over the past 18 months, Staab Thomas R Ii made no insider transaction in LENSAR Inc (LNSR). Other recent insider transactions involving LENSAR Inc (LNSR) include a net purchase of 10,000 shares made by Gary M Winer , and a net purchase of 50,000 shares made by Aimee S Weisner .
In summary, during the past 3 months, insiders sold 0 shares of LENSAR Inc (LNSR) in total and bought 5,495 shares, with a net purchase of 5,495 shares. During the past 18 months, 0 shares of LENSAR Inc (LNSR) were sold and 60,000 shares were bought by its insiders, resulting in a net purchase of 60,000 shares.
LENSAR Inc (LNSR)'s detailed insider trading history can be found in Insider Trading Tracker table.
LENSAR Inc Insider Transactions
Staab Thomas R Ii Mailing Address
Above is the net worth, insider trading, and ownership report for Staab Thomas R Ii. You might contact Staab Thomas R Ii via mailing address: C/o Inspire Pharmaceuticals, Inc., 4222 Emperor Blvd., Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
